Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer (2021-2026)
Experts
Honorary Professor
Janet Hardy
Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences